[New] Strengthening the global virology workforce and supporting the next generation of scientists will be just as important as the scientific tools we develop.
EurekAlert!
[New] Complement Therapeutics's CTx001, an investigational gene therapy that targets complement pathways in geographic atrophy, will be evaluated in a phase 1/2 trial in 2026.
PentaVision
[New] Official launch of the European Genomic Medicine Consortium Opportunity to meet the first CRISPR medicine patients.
CRISPR Medicine
[New] Calidi Biotherapeutics (NYSE American: CLDI) is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease.
GlobeNewswire
[New] The goals of the FYP represent the continuation of the 2017 State Council New Generation Artificial Intelligence Development Plan, which calls for China to become a world-leader in AI by 2030.
The Diplomat
[New] By technology, the generative AI segment is expected to grow at a significant CAGR of 22.9% from 2026 to 2035.
Precedence Research
[New] 71% expect to invest in generative and agentic AI over the next three to five years.
Supermarket News
[New] By 2026, more than 80% of enterprises will have used generative AI APIs and models or deployed gen AI-enabled applications in production environments.
Leadership Circle
[New] By 2026, over 80% of enterprises will have deployed Generative AI-enabled applications in production, marking a shift from experimentation to enterprise-scale adoption.
Claritus Consulting
[New] As faculty use of generative AI continues to increase, education technology experts predict agentic AI will shape higher education's ever-evolving relationship with AI in 2026.
Mimir's Well
[New] Adoption is skyrocketing across industries, with projections indicating that over 70% of businesses will be using generative AI in some capacity by the end of 2026.
InfoStream Global
[New] Based on internal data from industry analysts, generative AI is expected to have the most significant impact on business operations within the next two years, followed closely by cybersecurity mesh architecture.
InfoStream Global
[New] A second Starlink satellite has generated on-orbit debris in just over 3 months, threatening SpaceX's 10,151-satellite working constellation.
KeepTrack
[New] Micron Develops Stacked GDDR for AI Inference, Prototype to be Completed in 2027 Memory giant Micron is developing stacked GDDR as a next-generation memory specialized for AI inference processing, with a prototype expected to be completed in 2027.
Amiko Consulting
[New] Samsung Aims for 1-nanometer Manufacturing by 2030, 2-nanometer Yield Exceeds 60% Samsung Electronics is reportedly pushing hard to develop the next generation of advanced nodes, aiming to manufacture 1-nanometer processes by 2030 using new chiplet technology.
Amiko Consulting
[New] While the House and Senate bills would offset any lost Highway Trust Fund revenue with general funds, the tax suspension could raise the federal deficit and jeopardize the long-term sustainability of investments for highway and public transit programs.
WTOP News
[New] Major investments from industry leaders, including companies like General Intuition and World Labs, underscore the significant potential and rapid evolution of World Models in achieving general intelligence.
Radical Data Science
[New] Singapore will subsidise genetic testing for hereditary breast and ovarian cancer from December, addressing a high mutation rate (1 in 150 individuals).
ST
[New] Specific Biologics will apply CRISPR-Cas-adjacent Dualase editors within an ML-driven platform to predict highly specific genome edits, supported by a CAD $1.8 million grant.
CRISPR Medicine
[New] New York City-based Lexeo Therapeutics plans three safety and dosing clinical trials to increase protective APOE gene variants and reduce harmful APOE gene variants in people with the highest-risk gene APOE4 / APOE4 gene combination who have early Alzheimer's disease.
Live Science
[New] Physical inactivity is one of the leading modifiable risk factors for non-communicable diseases (NCDs) and is responsible for an estimated 5% of all adult deaths, drives US$ 54 billion in annual direct health-care costs, and generates a further $14 billion in productivity losses.
Open Access Government
[New] Over 50% of Chinese consumers now utilize generative AI assistants daily to plan itineraries, optimize travel budgets, and manage logistics.
Travel And Tour World
Last updated: 05 April 2026
Hi,
Would you like a quick online demo of our service from an experienced member of our team?
